|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2024―Feb―29 |
Type 1 diabetes mellitus following COVID-19 vaccination: a report of two cases and review of literature |
Shota Mochizuki, Junnosuke Miura, Kiwako Ucida, Ryo Kubota, Hirona Fujikawa, Satoshi Takagi, et al. (+6) Naoshi Yoshida, Sachiko Ootake, Chika Fujimori, Akihito Shinohara, Junji Tanaka, Tetsuya Babazono |
2 |
[GO] |
2023―Aug―07 |
Glucose control in the early phase of hospitalization is associated with severe prognosis in coronavirus disease 2019 (COVID-19) patients with diabetes in Japan |
Yukiyoshi Okauchi, Ryuki Sakamoto, Tomoko Kaketaka, Eri Yamabayashi, Motohiro Kubori, Shinya Inada, et al. (+5) Osamu Morimura, Yasushi Otani, Kinya Abe, Tsutomu Nishida, Hiromi Iwahashi |
3 |
[GO] |
2023―Jul―31 |
Anti-GAD antibody-positive fulminant type 1 diabetes developed following SARS-CoV-2 vaccination |
Tomohito Izumi, Hironobu Takahashi, Hironori Takahashi |
4 |
[GO] |
2023―Jul―01 |
Impact of prediabetes with a high risk of diabetes stratified by glycated hemoglobin level on the severity of coronavirus disease 2019 during admission |
Seizaburo Masuda, Tetsuya Yamada, Nozomi Hanzawa |
5 |
[GO] |
2022―Dec―23 |
Diabetic ketoacidosis after the second dose of SARS-CoV-2 mRNA vaccination in a patient with pembrolizumab-induced fulminant type 1 diabetes |
Kohei Nishino, Kimiko Nakagawa, Eriko Yase, Mariko Terashima, Takashi Murata |
6 |
[GO] |
2022―May―05 |
Antibody levels in people with diabetes after one dose of the ChAdOx1 nCoV-19 (AZD1222) vaccine |
Vimonsri Rangsrisaeneepitak, Thachanun Porntharukchareon, Bothamai Dechates, Supamas Sirisreetreerux, Kriangkrai Tawinprai |
7 |
[GO] |
2022―Mar―08 |
Seasonal variations and the influence of COVID-19 pandemic on hemoglobin A1c, glycoalbumin, and low-density lipoprotein cholesterol |
Kohzo Takebayashi, Mototaka Yamauchi, Kenji Hara, Takafumi Tsuchiya, Koshi Hashimoto |
8 |
[GO] |
2021―May―12 |
Evaluation of perceived fears of COVID-19 virus infection and its relationship to health-related quality of life among patients with diabetes mellitus in Egypt during pandemic: a developing country single-center study |
Mohamed Abdelghani, Mohamed G. Hamed, Amira Said, Eman Fouad |
9 |
[GO] |
2021―Apr―19 |
The effect of COVID-19 pandemic on the lifestyle and glycemic control in patients with type 1 diabetes: a retrospective cohort study |
Yukako Hosomi, Chihiro Munekawa, Yoshitaka Hashimoto, Takuro Okamura, Fuyuko Takahashi, Rena Kawano, et al. (+8) Hanako Nakajima, Saori Majima, Takafumi Senmaru, Naoko Nakanishi, Emi Ushigome, Masahide Hamaguchi, Masahiro Yamazaki, Michiaki Fukui |
10 |
[GO] |
2021―Mar―23 |
Diabetes-related acute metabolic emergencies in COVID-19 patients: a systematic review and meta-analysis |
Vasileios P. Papadopoulos, Marios-Vasileios Koutroulos, Dimitra-Georgia Zikoudi, Stefania-Aspasia Bakola, Peny Avramidou, Ntilara Touzlatzi, Dimitrios K. Filippou |
11 |
[GO] |
2021―Mar―01 |
Clinical features resembling subcutaneous insulin resistance observed in a patient with type 2 diabetes and severe COVID-19-associated pneumonia: a case report |
Atsushi Satomura, Yoichi Oikawa, Shunpei Nakanishi, Sotaro Takagi, Gen Mizutani, Shinichiro Iida, et al. (+6) Hideto Nakayama, Yoshiyuki Haga, Makoto Nagata, Shigefumi Maesaki, Toshihide Mimura, Akira Shimada |
12 |
[GO] |
2020―Oct―28 |
COVID-19-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes on SGLT2 inhibitor: a case report |
Daniel Valente Batista, Carla Antoniana Ferreira de Almeida Vieira, Thomaz Alexandre Costa, Eduardo Gomes Lima |
13 |
[GO] |
2020―Sep―30 |
Behavioral changes in patients with diabetes during the COVID-19 pandemic |
Miyako Kishimoto, Takuya Ishikawa, Masato Odawara |
14 |
[GO] |
2020―Jun―19 |
Ethics and practical mitigations for ongoing clinical trials during the COVID-19 pandemic |
Shota Suzuki, Yukie Ito, Shu Kasama, Takashi Murata, Munehide Matsuhisa, Masato Kasahara |